BIO Deutschland Member Directory

Regensburg, Germany

2bind is a service provider for molecular interaction analyses. The company offer tailor-made biophysics services and solutions in the areas of Drug Discovery, Antibody Research, Aptamer Characterization, and Protein Biophysics. The company's product 2bind BufferToolbox® provides access to high-end formulation development for proteins and antibodies.

3B Pharmaceuticals GmbH

Berlin, Germany

3B Pharmaceuticals GmbH (3BP) is a biotechnology company developing targeted radiopharmaceutical drugs and diagnostics for oncology indications with a high unmet medical need. The company is active in peptide discovery and optimization and has built a technology platform extending from hit identification to early clinical development. Technologies are applied to both in-house and collaborative R&D.

4SC AG

Planegg-Martinsried, Germany

4SC AG is a clinical-stage biopharmaceutical company developing small-molecule drugs that target key indications in cancer with high unmet medical needs. 4SC’s pipeline is protected by a comprehensive portfolio of patents and currently comprises one drug candidate in clinical development.

AATec Medical GmbH

Munich, Germany

AATec Medical is a biotech startup based in Munich. The company develops novel biopharmaceuticals based on recombinant alpha-1 antitrypsin (AAT) for inhalation for the treatment of pulmonary inflammation and infectious diseases, such as respiratory virus infections, ARDS and allergic asthma. AATec Medical's products will be administered using cutting-edge protein nebulization technology for inhalation.

AB Enzymes GmbH

Darmstadt, Germany

AB Enzymes develops and distributes enzymes. The products range from food enzymes for baking and beverages to enzymes for animal feed, textile technology and the detergents industry. AB Enzymes’ focus in the biofuel market is in the use of lignocellulosic biomass to produce transport fuels.

Abalos Therapeutics GmbH

Düsseldorf, Germany

Abalos Therapeutics develops a novel anti-cancer approach that provides the full breadth of the immune system’s power specifically against cancer cells. Abalos’ arenavirus-based drug candidates are designed to awake precise immune responses and activate all relevant immune cell types against primary tumors and metastases. The company's aim is to harness the unique immune stimulation of the arenavirus to develop a novel anti-cancer approach that provides the full breadth of the immune system’s...

AbbVie Germany GmbH & Co. KG

Wiesbaden, Germany

AbbVie Deutschland GmbH & Co. KG is a global, research-based biopharmaceutical company. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases.

Acaryon GmbH

Berlin, Germany

Acaryon GmbH is a company specialized in the development of specific and innovative natural microorganisms for probiotic and microbiome applications for the pharmaceutical and food industry. Moreover, Acaryon provides analytical services for a different range of purposes.

acCELLerate GmbH

Hamburg, Germany

acCELLerate GmbH develops cell-based assay kits for applications in research, safety, quality control, and diagnostics. The company's instaCELL bioassays are based on ready-made cryopreserved cells which can be directly used in an assay without prior cultivation or even cell counting. The kits contain all required components, assay plates, medium, reagents, controls, and cells.

Acousia Therapeutics GmbH

Tübingen, Germany

Acousia is developing a series of small molecule drug candidates for local and systemic treatment of different forms of hearing loss. The company's lead product ACOU085 is a proprietary, small-molecule otoprotective drug candidate, which is currently being tested in a Phase 1b clinical trial involving age-related hearing loss (ARHL) patients.

ACROBiosystems Group

Frankfurt, Germany

ACROBiosystems Group is a biotechnology company aims to help global biopharmaceutical and health industries by providing products and business models innovation.

acromion GmbH

Frechen, Germany

acromion GmbH is a Contract Research Organization (CRO) with experience in medical and bioscientific research. The company provides full service in clinical trial organization and conduct, clinical monitoring, clinical data management, statistics and medical writing for state-of-the-art clinical trial and NIS performance.

adivo GmbH

Puchheim, Germany

Adivo GmbH, a German biotech company specializing in generating species-specific therapeutic antibodies for companion animals. The company develops new technologies to expand the range of therapeutic options for pet cancer and chronic inflammatory conditions.

Adrenomed AG

Hennigsdorf, Germany

Adrenomed AG is a clinical-stage biopharmaceutical company. The company's mission is to rescue vascular integrity in order to save the lives of critically ill patients with limited treatment options. The company's lead product candidate Adrecizumab (INN: enibarcimab) is a non-blocking monoclonal antibody. Adrecizumab targets the vasoprotective peptide Adrenomedullin, an essential regulator of vascular integrity.

Aeterna Zentaris GmbH

Frankfurt, Germany

Aeterna Zentaris is a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products focused on areas of significant unmet medical need. The Company's lead product, macimorelin (Macrilen™; Ghryvelin®), is the first and only U.S. FDA and European Commission approved oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). Aeterna Zentaris is dedicated to the development of therapeutic assets across...

Affimed N.V

Heidelberg, Germany

Affimed is a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer by actualizing the untapped potential of the innate immune system. The company’s proprietary ROCK® platform enables a tumor-targeted approach to recognize and kill a range of hematologic and solid tumors, enabling a broad pipeline of wholly-owned and partnered single agent and combination therapy programs. The ROCK® platform predictably generates customized innate cell...

AGC Biologics – Heidelberg

Heidelberg, Germany

AGC Biologics is a global contract development and manufacturing organization (CDMO), dedicated to the development and manufacture of biopharmaceuticals, from pre-clinical to commercial. The company offers deep industry expertise and uniquely customized services for the scale-up and cGMP manufacture of protein-based therapeutics, from pre-clinical to commercial production, using mammalian and microbial production systems.

AiCuris Anti-infective Cures AG

Wuppertal, Germany

AiCuris is a pharmaceutical company focused on the discovery, research and development of antiviral and antibacterial agents for the treatment of severe and potentially life-threatening infectious diseases.The company’s first product, Letermovir (Prevymis®) is a therapy for human cytomegalovirus (HCMV) infections.

AIT Austrian Institute of Technology GmbH

Vienna, Austria

AIT Austrian Institute of Technology GmbH is a non-university research institution and the molecular diagnostics business unit within the Health & Environment Department. AIT provides research and technological development to understand the basic innovations for the next generation of infrastructure-related technologies in the fields of energy, mobility systems, low-emission transport, health & bioresources, digital safety & security, vision, automation & control, and technology experience.

AKAMPION

Berlin, Germany

akampion provides full-service public relations, investor relations and marketing communications to healthcare and technology companies. The company's services include Reputation management, strategic advice, integrated corporate communications, storytelling, public relations, investor relations, product PR, perception studies, marketing, online PR, media training and employee branding.